Bank of Nova Scotia’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank of Nova Scotia’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.5K	Buy	+200	New	+$25K	﹤0.01%	1064
2025 Q1	–	Sell	-800	Closed	-$72K	–	1130
2024 Q4	$72K	Hold	800	–	–	﹤0.01%	998
2024 Q3	$79K	Sell	800 -200	-20%	-$19.6K	﹤0.01%	958
2024 Q2	$92.7K	Buy	1,000 +200	+25%	+$17.9K	﹤0.01%	956
2024 Q1	$75.9K	Buy	800 +600	+300%	+$55.7K	﹤0.01%	982
2023 Q4	$17.9K	Hold	200	–	–	﹤0.01%	993
2023 Q3	$14.6K	Hold	200	–	–	﹤0.01%	995
2023 Q2	$16.6K	Buy	+200	New	+$16.7K	﹤0.01%	1017
2022 Q3	–	Sell	-2,525	Closed	-$188K	–	1244
2022 Q2	$188K	Buy	+2,525	New	+$190K	﹤0.01%	1123
2019 Q1	–	Sell	-81,700	Closed	-$5.86M	–	938
2018 Q4	$5.86M	Buy	+81,700	New	+$6.58M	0.03%	371

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Nova Scotia's XBI Position: Q1 2026 in Review

Bank of Nova Scotia opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 22,509 shares worth $2.87M. The stake represents 0.01% of the portfolio and ranks #681 among its holdings. This is a return to the name: Bank of Nova Scotia previously reported a position in XBI as recently as Q1 2025.

Bank of Nova Scotia first reported a position in XBI in Q1 2017 and has held it in 31 quarters since. The position peaked at $480M in Q4 2019. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Bank of Nova Scotia held 22,509 shares of State Street SPDR S&P Biotech ETF worth $2.87M as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Bank of Nova Scotia position in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #681 holding.
Bank of Nova Scotia first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 31 quarters since.
Bank of Nova Scotia's State Street SPDR S&P Biotech ETF position peaked at $480M in Q4 2019.
815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.